2024-09-18 - Analysis Report
## INTU Stock Analysis

**Company Overview:**  Intuitive Surgical, Inc. (INTU) is a medical device company specializing in minimally invasive surgical systems.

**1. Performance Comparison**

INTU's cumulative return is **126.76%**, outperforming the S&P 500 (VOO) with its cumulative return of **89.02%**. The current divergence is **37.74**, indicating that INTU has outperformed VOO by a considerable margin. The relative divergence of **27.14** suggests that INTU's performance is currently within the upper 27% of its historical performance against VOO.

**2. Recent Price Trend**

* **Closing Price:** 646.25
* **5-Day Moving Average:** 645.09
* **20-Day Moving Average:** 636.84
* **60-Day Moving Average:** 638.6

The recent price trend shows a slight upward momentum, with the closing price above all moving averages, suggesting potential for further growth.

**3. Technical Indicators**

* **RSI:** 65.16
* **PPO:** 0.42
* **Delta_Previous_Relative_Divergence:** -3.87 (Short-term decline)
* **Expected_Return:** 101.57% (5-year expected return)

The RSI suggests that INTU is in the overbought territory, but the PPO indicates a positive momentum. The short-term decline in the relative divergence indicates a potential slowdown in growth, while the high expected return remains promising.

**4. Recent Earnings & Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-05-23 | 8.53 | 6.74 B$ |
| 2024-02-22 | 1.26 | 3.39 B$ |
| 2023-11-28 | 0.86 | 2.98 B$ |
| 2023-05-23 | 7.44 | 6.02 B$ |
| 2024-05-23 | 7.44 | 6.02 B$ |

The most recent earnings report for Q2 2024 showed EPS of $8.53, exceeding analysts' estimates of $7.44. Revenue also came in above expectations at $6.74 Billion, showcasing strong growth and demand for their products. This positive trend suggests further growth potential in the near future.

**5. Overall Analysis**

INTU has consistently outperformed the S&P 500, displaying strong financial performance. The recent earnings report highlights positive growth and exceeds market expectations. While technical indicators suggest some short-term slowdown, the overall outlook for INTU remains positive. 

**6. Conclusion**

INTU demonstrates a strong track record of growth and profitability. Its recent earnings and future outlook suggest further potential for continued success. While the current overbought conditions and short-term decline in relative divergence warrant caution, INTU remains an attractive investment for investors seeking long-term growth opportunities in the healthcare sector. 
